Cancer Monoclonal Antibodies Market 2015 Key Insights and 2020 Foreca Oct.2016 | Page 2

Global Cancer Monoclonal Antibodies Market According to the report "Cancer Monoclonal Antibodies Market", published by Market Data Forecast, the global market is projected to reach USD 45 Billion by 2020, at a CAGR of 11.2% from 2015 to 2020. For full report refer to http://www.marketdataforecast.com/market-reports/globalcancer-monoclonal-antibodies-market-185/ Monoclonal Antibodies (mAbs) are mono-specific antibodies bodies comprising of identical immune cells that are clones of a single parent cells and are directed to a specific cellular targets. Thus Monoclonal Antibodies are highly customizable due to its specific nature and can play a crucial role in eliminating the cancerous cell while sparing the normal cells during the cancer treatment. The monoclonal antibodies are proved to be more effective than chemotherapies and drugs for cancer treatment due to its specificity. Free sample for the report is available at http://www.marketdataforecast.com/marketreports/global-cancer-monoclonal-antibodies-market-185/request-sample The dramatic increase in the cancer cases has led many pharmaceutical companies to invest in monoclonal antibodies market. Increasing investment in research and development of genomic studies, technological advancements in genetic sequencing and target gene selection, specificity of monoclonal antibodies to target only the cancer cells with no side effects are the driving forces of the market. With the increased prevalence of cancer, it is expected to grow lucratively in the next 5 years with the presence of strong products in the pipeline. Global Monoclonal Antibodies Market is segmented on the basis of application, type and Conjugated Cancer therapies. 1.By Application         Liver Breast Brain Blood Hodgkins and Non-Hodgkins lymphoma Colorectal Leukaemia And others 2.By Type    Murine Antibodies Chimeric and Humanised Antibodies Fully Humanized Antibodies 3.Conjugated Cancer Therapies  Immunoliposome +1 888-702-9626 | www.marketdataforecast.com | [email protected]